ImmunoGen, Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ImmunoGen with three other
companies in this sector in the United States:
Alnylam Pharmaceuticals, Inc.
sales of $47.16 million
China Yct International Group, Inc.
Integrated Biopharma, Inc.
During the year ended June of 2016, sales at
ImmunoGen were $60.00 million.
decrease of 29.9%
versus 2015, when the company's sales were $85.54 million.